Resistance to podophyllotoxin is not commonly reported in the context of viral infections such as warts. However, in cancer therapy, resistance can develop as with many chemotherapeutic agents. Cancer cells may evolve to bypass the drug's mechanism of action or develop efflux pumps to remove the drug. Research into overcoming resistance continues to be an important area in oncology.
